Top Ten Retail Investor Buys & Sells for week ending 8 June 2007

Angus Rigby, Chief Executive Officer, TD Waterhouse, commented: Once again this week, the Royal Bank of Scotland (RBS) takeover wagon rolls on as the talk surrounding their proposed £48bn acquisition of Dutch banking giant, ABN Amro continues. Fresh speculation surrounds this FTSE100 stalwart as it was revealed that RBS chiefs are to meet with representatives of the UNI Confederation of Trade Unions to quell fears over the future of employees, should the deal go ahead. Despite the legal controversy surrounding the sale of LaSalle bank, the American arm of ABN Amro, RBS released a statement denying that they had held conciliation talks with Bank of America and that they await the decision on the legality of the sale in late June or early July. All of this did not prevent RBS trading up 1.24pc on the month to 654 pence per share on Thursday 7 June.

The Pharmaceutical industry came alive this week over the announcement by GlaxoSmithKline (GSK) that their pipeline breast cancer drug Tykerb is displaying positive results in early trials. GSK increased market confidence with a further announcement on Wednesday that their cervical cancer drug Cervarix had produced a 100pc immune response in women up to the age of 55 following an 18 month course.

The share price rose by 1.57pc to 1,292 pence per share on Thursday 7 June following GSKs rebuttal of accusations that their diabetes drug Avandia increased the risk of heart problems. The FDA is still demanding stronger 'black box' warnings on the product and GSK is still trading down 10.65pc on the month.

Telecoms giant Vodafone (VOD) has come under much scrutiny this week amidst speculation of a possible break-up or takeover. On Thursday 7 June, the share price strengthened on the confirmation that VOD had received a letter from an activist shareholder group asking it to consider a number of restructuring options. Glen Cooper's Efficient Capital Structures, the rebel shareholder group circling VOD, backed by former Marconi boss John Mayo's Beehive Capital Investment Fund, have laid out prospective plans to release up to £38bn of value from the group. Trading was strong early on Thursday with the share price up 2.5p to 157.6 pence per share.

Top 10 Buys
1 Glaxosmithkline
2 Royal Bank of Scotland
3 Vodafone Group
4 Tanfield Group
5 Bradford & Bingley
6 British Airways
7 Nighthawk Energy
8 Partygaming
9 Eurotunnel PLC/SA
10 Toledo Mining


Top 10 Sells
1 Vodafone Group
2 Royal Bank of Scotland
3 Partygaming
4 Barclays
5 Tanfield Group
6 BHP Billiton PLC
7 Glaxosmithkline
8 Carphone Warehouse
9 Eurotunnel PLC/SA
10 BT Group